Scientific Paper: Selected Aspects of Botulinum Toxin Therapy on Motor and Non-motor Symptoms of Cervical Dystonia

Objectives
Cervical dystonia is a neurological disease-causing neck muscle contractions, resulting in abnormal head and neck movements and postures. In addition to the core motor symptoms, recent research has focused on non-motor symptoms (NMS) that significantly impact quality of life. These NMS include pain, depression, anxiety, cognitive impairment, fatigue, various sleep disturbances and sexual dysfunction. According to recent studies, botulinum toxin, which is utilized to alleviate pathological muscle contractions, also has an effect on some NMS, for example pain. The aim of our study was to determine whether botulinum toxin injections have an impact on depression, and whether there is a correlation between functional improvement after botulinum toxin treatment measured in the 10-metre walk time and depressive symptoms.

Design
It was monocenter, prospective, observational study. 30 patients with idiopathic cervical dystonia and 30 healthy age and sex matched subjects were included.
Psychological and functional assessment was performed in both groups, including Beck Depression Inventory (BDI) and 10-metre walk time. Study group underwent the assessment in two time points: 1. before and 2. in 4-8 weeks after botulinum toxin injections.

Results
The BDI score in cervical dystonia patients 4-8 weeks after botulinum toxin injections significantly improved compared to baseline. Motor improvement was statistically significant and correlated with the improvement in depressive scale. In summary, the efficacy of botulinum toxin in alleviating motor symptoms od dystonia is well-documented, but there is also some effect of certain NMS, like depression. The precise mechanism of action is not yet fully understood, but it has been hypothesized that botulinum toxin exerts its effect also through a central mechanism. However, the relationship between improvements in motor and non-motor symptoms remains unclear and needs further investigation.

Conclusions
In cervical dystonia, both motor and non-motor symptoms significantly impact quality of life. Motor symptoms cause physical disability, while non-motor symptoms exacerbate distress. This study highlights the therapeutic potential of botulinum toxin beyond motor symptoms, underscoring the need for further research into its effects on non-motor symptoms.

Cervical dystonia is a neurological disease causing neck muscle contractions, resulting in abnormal head and neck movements and postures. In addition to the core motor symptoms, recent research has focused on non-motor symptoms (NMS) that significantly impact quality of life. These NMS include pain, depression, anxiety, cognitive impairment, fatigue, various sleep disturbances and sexual dysfunction. According to recent studies, botulinum toxin, which is utilized to alleviate pathological muscle contractions, also has an effect on some NMS, for example pain. The aim of our study was to determine whether botulinum toxin injections have an impact on depression, and whether there is a correlation between functional improvement after botulinum toxin treatment measured in the 10-metre walk time and depressive symptoms.

Methods

It was monocenter, prospective, observational study. 30 patients with idiopathic cervical dystonia and 30 healthy age and sex matched subjects were included. Psychological and functional assessment was performed in both groups, including Beck Depression Inventory (BDI) and 10-metre walk time. Study group underwent the assessment in two time points: 1. before and 2. in 4-8 weeks after botulinum toxin injections.

Results

The BDI score in cervical dystonia patients 4-8 weeks after botulinum toxin injections significantly improved compared to baseline. Motor improvement was statistically significant and correlated with the improvement in depressive scale. In summary, the efficacy of botulinum toxin in alleviating motor symptoms od dystonia is well-documented, but there is also some effect of certain NMS, like depression. The precise mechanism of action is not yet fully understood, but it has been hypothesized that botulinum toxin exerts its effect also through a central mechanism. However, the relationship between improvements in motor and non-motor symptoms remains unclear and needs further investigation.

Conclusion

In cervical dystonia, both motor and non-motor symptoms significantly impact quality of life. Motor symptoms cause physical disability, while non-motor symptoms exacerbate distress. This study highlights the therapeutic potential of botulinum toxin beyond motor symptoms, underscoring the need for further research into its effects on non-motor symptoms.